Updated Jul 16, 2026
Soergel David has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $952K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | S — Open-market sale | 1.0K | $495.74 | $517K |
| 2026-05-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | S — Open-market sale | 844 | $515.90 | $435K |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 4.4K | $0.00 | |
| 2025-05-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 7.5K | $0.00 |
Soergel David is a corporate insider — currently tracked as Chief Medical Officer of MADRIGAL PHARMACEUTICALS, INC. (MDGL). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($952K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Soergel David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.